Home › Pneumonia › Florida › Hialeah
Pneumonia clinical trials in Hialeah, FL
4 studies for Pneumonia are looking for participants at sites in and around Hialeah (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RecruitingPhase 3
- Qway Research LLC, Hialeah
- Global Health Research Center, Inc., Miami Lakes · 4 mi away
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RecruitingPhase 3
- BRP- Hialeah Hospital, Hialeah
A Study of COVID-19 Vaccine(s) in Children and Adults
RecruitingPhase 3Healthy volunteers welcome
- Indago Research & Health Center, Inc, Miami Lakes · 4 mi away
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
RecruitingPhase 4Healthy volunteers welcome
- Palm Springs Community Health Center, Miami Lakes · 4 mi away
About Pneumonia
Pneumonia is an infection in one or both of the lungs. Symptoms of pneumonia vary to mild to severe. Read about the signs of pneumonia.
More about Pneumonia on MedlinePlus
Pneumonia trials in other cities
- Houston, TX8 studies
- Salt Lake City, UT6 studies
- Chicago, IL6 studies
- Washington, DC5 studies
- Durham, NC5 studies
- St. Louis, MO4 studies
- Dallas, TX4 studies
- Atlanta, GA4 studies
- Philadelphia, PA4 studies
- Los Angeles, CA4 studies
- New York City, NY4 studies
- Boston, MA4 studies
Other studies in Hialeah
- Schizophrenia13 studies
- Obesity13 studies
- Heart Failure12 studies
- Steatotic Liver Disease11 studies
- Type 2 Diabetes11 studies
- COPD10 studies
- Overweight10 studies
- Long COVID8 studies
- Viral Infections6 studies
- Lung Diseases6 studies
- Major Depressive Disorder6 studies
- Alzheimer's Disease6 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.